Literature DB >> 19700315

A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.

Hong C Shen1, Fa-Xiang Ding, Qiaolin Deng, Suoyu Xu, Xinchun Tong, Xiaoping Zhang, Yuli Chen, Gaochao Zhou, Lee-Yuh Pai, Magdalena Alonso-Galicia, Sophie Roy, Bei Zhang, James R Tata, Joel P Berger, Steven L Colletti.   

Abstract

Distinct from previously reported urea and amide inhibitors of soluble epoxide hydrolase (sEH), a novel class of inhibitors were rationally designed based on the X-ray structure of this enzyme and known amide inhibitors. The structure-activity relationship (SAR) study was focused on improving the sEH inhibitory activity. Aminobenzisoxazoles emerged to be the optimal series, of which a potent human sEH inhibitor 7t was identified with a good pharmacokinetics (PK) profile. The strategy of employing aminoheterocycles as amide replacements may represent a general approach to develop mimics of known hydrolase or protease inhibitors containing an amide moiety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700315     DOI: 10.1016/j.bmcl.2009.08.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

Review 2.  Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

3.  1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

Authors:  Sampath-Kumar Anandan; Heather Kay Webb; Dawn Chen; Yi-Xin Jim Wang; Basker R Aavula; Sylvaine Cases; Ying Cheng; Zung N Do; Upasana Mehra; Vinh Tran; Jon Vincelette; Joanna Waszczuk; Kathy White; Kenneth R Wong; Le-Ning Zhang; Paul D Jones; Bruce D Hammock; Dinesh V Patel; Randall Whitcomb; D Euan MacIntyre; James Sabry; Richard Gless
Journal:  Bioorg Med Chem Lett       Date:  2010-12-13       Impact factor: 2.823

4.  Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.

Authors:  Christophe Morisseau; Svitlana Pakhomova; Sung Hee Hwang; Marcia E Newcomer; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2013-05-06       Impact factor: 2.823

5.  Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.

Authors:  Kin Sing Stephen Lee; Jen C Ng; Jun Yang; Sung-Hee Hwang; Christophe Morisseau; Karen Wagner; Bruce D Hammock
Journal:  Bioorg Med Chem       Date:  2020-08-31       Impact factor: 3.641

6.  Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.

Authors:  Rania S Sulaiman; Bomina Park; Sardar Pasha Sheik Pran Babu; Yubing Si; Rakshin Kharwadkar; Sayak K Mitter; Bit Lee; Wei Sun; Xiaoping Qi; Michael E Boulton; Samy O Meroueh; Xiang Fei; Seung-Yong Seo; Timothy W Corson
Journal:  ACS Chem Biol       Date:  2017-12-01       Impact factor: 5.100

Review 7.  Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.

Authors:  John D Imig
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

8.  Design, synthesis and biological evaluation of 4-benzamidobenzoic Acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors.

Authors:  Elham Rezaee Zavareh; Mahdi Hedayati; Laleh Hoghooghi Rad; Soraya Shahhosseini; Mehrdad Faizi; Sayyed Abbas Tabatabai
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 9.  Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.

Authors:  Amarjyoti Das Mahapatra; Rinku Choubey; Bhaskar Datta
Journal:  Molecules       Date:  2020-11-24       Impact factor: 4.411

10.  A convenient one-pot synthesis of N-substituted amidoximes and their application toward 1,2,4-oxadiazol-5-ones.

Authors:  Wong Phakhodee; Chuthamat Duangkamol; Nitaya Wiriya; Mookda Pattarawarapan
Journal:  RSC Adv       Date:  2018-11-14       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.